Cosmetic Enhancement Or Care Patents (Class 514/18.8)
-
Publication number: 20140309173Abstract: The invention provides compositions for stimulating the formation of one or more extracellular matrix components that contain a lipoaminoacid derivative of the tripeptide carnosine such as N-Octanoyl Carnosine. Also provided are compositions containing N-Octanoyl Carnosine in combination with selected tripeptide and/or tetrapeptides as well as pharmaceutical and/or cosmetic compositions containing such compositions. The invention further provides methods of using the compositions and compositions of the invention to treat, alleviate, and/or ameliorate a symptom, condition, disorder, or disease of the skin or mucosa, wherein the symptom, condition, disorder, or disease is associated with changes in extracellular matrix components.Type: ApplicationFiled: March 10, 2014Publication date: October 16, 2014Inventor: Frank Dreher
-
Publication number: 20140309157Abstract: The present invention relates to a WNT-derived novel peptide and use thereof. WNT-derived peptide of the present invention possesses identical or similar activities to natural-occurring WNT protein, and has much higher stability and skin penetration potency than natural-occurring WNT protein. Therefore, the composition containing the present peptide not only shows excellent effects on improvement in hair loss (for example, promotion of hair growth or production of hair), but also has superior efficacies on treatment of a WNT signal transduction pathway-related disorder. In addition, the outstanding activity and stability of the present peptide described above may be greatly advantageous in application to pharmaceutical compositions, quasi-drugs and cosmetics.Type: ApplicationFiled: May 9, 2012Publication date: October 16, 2014Applicant: CAREGEN CO., LTD.Inventors: Yong Ji Chung, Eun Mi Kim
-
Publication number: 20140303080Abstract: N-acyldipeptide derivatives are described. Compositions comprising the N-acyldipeptide derivatives are therapeutically effective for topical or systemic administration to alleviate or improve conditions, disorders, diseases, symptoms or syndromes associated with a tumor, cancer, immune, nervous, vascular, musculoskeletal or cutaneous system, or other tissue or system in a subject.Type: ApplicationFiled: October 31, 2012Publication date: October 9, 2014Inventors: Ruey J. Yu, Eugene J. Van Scott
-
Patent number: 8853361Abstract: The invention relates to a sterile preparation which can be implanted on or in organic tissues, comprising: a natural or modified globin material which is insoluble at physiological pH and/or a material obtainable from globin which has been modified to be soluble at physiological pH, the said materials being biocompatible and biodegradable in the organism; an agent selected from natural or synthetic polymeric adhesive agents, polymeric tissue enhancement or filling agents, more particularly an agent based on crosslinked hyaluronic acid or on polylactic acid, and a polymeric wound cicatrization agent, specifically oxidized cellulose; with the provisos that, if the preparation comprises the said material obtainable from globin modified so as to be at least partly soluble, the said polymeric adhesive agent, if present, is not hyaluronic acid or carboxymethylcellulose and the said polymeric enhancement or filling agent, if present, is an agent based on crosslinked hyaluronic acid, and that, if the preparation comType: GrantFiled: January 24, 2007Date of Patent: October 7, 2014Assignee: KhorionyxInventor: Jean-Louis Tayot
-
Publication number: 20140296155Abstract: A skin cream and method for making and applying the skin cream having, e.g., a copper component, an ascorbic acid component, a lipid component and a peptide component. The peptide component can include palmitoyl pentapeptide (KTTLS) or hydrolized serecin. The copper component can be a copper solubilizing formulation. The copper solubilizing formulation can include one of (I) copper and a copper-complexing peptide and/or (ii) a copper-complexing protein. The combination of copper and the ascorbic acid component can prevent or reduce a destabilization of the ascorbic acid component.Type: ApplicationFiled: September 24, 2012Publication date: October 2, 2014Inventors: Amy NEWBURGER, Konstantinos M. LAHANAS
-
Publication number: 20140287006Abstract: The present invention relates to degradation-stabilised, biocompatible collagen matrices which are distinguished in particular by the fact that they contain soluble collagen and peptide constituents, to processes for the preparation of such collagen matrices, which processes include in particular chemical crosslinking with an epoxy-functional crosslinking agent, and to the use of the collagen matrices according to the invention as a cosmetic or pharmaceutical agent, in particular for topical use, and as a wound treatment agent, as an implant or as a haemostatic agent in humans or animals, and as a scaffold for cell population in the biotechnology, basic research and tissue engineering field.Type: ApplicationFiled: March 28, 2014Publication date: September 25, 2014Inventors: Ralf Malessa, Anja Kassner
-
Publication number: 20140255455Abstract: The present invention relates to cosmetic compositions comprising polypeptides obtained or obtainable from Salmonidae hatching fluid, methods of producing said compositions and their use in various cosmetic applications to the skin, particularly for improving the cosmetic appearance of skin of a mammalian animal.Type: ApplicationFiled: June 25, 2012Publication date: September 11, 2014Applicant: AQUA BIO TECHNOLOGY ASAInventors: Bernt Th. Walther, Hans Kristian Leren, Fanny Fagot
-
Patent number: 8815814Abstract: The invention is directed to the cosmetic use of tetrapeptides according to formula (I) R1-Val-Leu-Leu-Lys-R2 (I) wherein R1 is linked to the NH2-terminal group of the peptide and is chosen from the group consisting of —H, a linear saturated or unsaturated or branched saturated or unsaturated acyl group having 1 to 24 carbon atoms, which may be functionalized by a —OH, —SH, —COOH or —CONH2 group wherein R2 is the terminal carboxylic group of the peptide either as —COOR3 or —CO—NH2, and wherein R3 is chosen from the group consisting of —H, a linear saturated or unsaturated or branched saturated or unsaturated alkyl group having 1 to 24 carbon atoms, which may be functionalized by a —OH, —SH, —COOH or —CONH2 group. The invention is also directed to the respective tetrapeptides and cosmetic compositions containing these.Type: GrantFiled: March 5, 2011Date of Patent: August 26, 2014Assignee: Cognis IP Management GmbHInventors: Vincent Bardey, Philippe Moussou, Christine Jeanmaire, Louis Danoux
-
Publication number: 20140235547Abstract: Disclosed herein are methods of restoring elasticity in tissue using tropoelastin containing compositions.Type: ApplicationFiled: September 27, 2012Publication date: August 21, 2014Inventors: Suzanne Marie Mithieux, Anthony Steven Weiss
-
Publication number: 20140234242Abstract: Disclosed is a method of firming skin or reducing the appearance of fine lines or wrinkles comprising topically applying, to skin in need thereof, a composition comprising palmitoyl tetrapeptide 7 and a dermatologically acceptable vehicle comprising water, glycerin, butylene glycol, propylene glycol, and a chelating agent, wherein topical application of the composition to the skin firms the skin or reduces the appearance of fine lines or wrinkles, and wherein the composition is not a sunless tanning composition.Type: ApplicationFiled: March 24, 2014Publication date: August 21, 2014Applicant: MARY KAY INC.Inventors: Dawn Burke-Colvin, Michelle Hines, David Gan
-
Publication number: 20140234382Abstract: The present invention provides nanoparticle compositions including one or more peptides. The present invention achieves transdermal delivery of such peptides without the need for peptide modification, or for use of chemical or mechanical abrasion or disruption of skin.Type: ApplicationFiled: February 22, 2014Publication date: August 21, 2014Applicant: Anterios, Inc.Inventors: Jonathan EDELSON, Timothy KOTYLA
-
Patent number: 8809279Abstract: Peptide compounds of the following general formula (I): R1-(AA)n-X1-X2-X3-Lys-Lys-Gln-Lys-Trp-X4-(AA)p-R2 are disclosed herein. The peptide compounds can be used as Telomeric repeat-binding factor 2 (TRF2) protein-modulating compounds and have a preventive action on deoxyribonucleic acid (DNA) double-strand breaks. In addition, cosmetic compositions that include at least one peptide of general formula (I) in a physiologically acceptable medium are disclosed along with methods for preventing and/or treating cutaneous signs of aging and photoaging.Type: GrantFiled: April 27, 2012Date of Patent: August 19, 2014Assignee: ISP Investments Inc.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Patent number: 8796217Abstract: The use of transesterified olive oil for increasing the penetration rate of cosmetically-active and/or dermatologically-active ingredients or as cosmetic moisturizer is disclosed.Type: GrantFiled: October 21, 2008Date of Patent: August 5, 2014Assignee: Hallstar Italia S.R.L.Inventors: Sergio Amari, Alain Thibodeau
-
Publication number: 20140199320Abstract: The invention provides inhibitors capable of binding to a member of the inflammasome group comprised of IL-1?, IL-1 receptor type 1, NLRP3, ASC, Caspase-1 and cathepsin B with a dissociation constant of 10-8 mol/l or smaller for the prevention and treatment of acne, specifically an antibody, an antibody fragment, an antibody-like molecule, an oligopeptide of 6 to 30 amino acid residues, a nucleic acid aptamer molecule of 10 to 75 nucleotides in length or a soluble polypeptide comprising a contiguous amino acid sequence of at least 30 amino acids comprised within the protein sequence of a member of the group comprised of IL-1?, IL-1 receptor type 1, IL-1 receptor type 2, NLRP3, ASC and Caspase-1. Similarly, an interfering RNA or an antisense modulator of gene expression of IL-1?, I L-1? receptor type 1, NLRP3, ASC, Caspase-1 and cathepsin B are provided for the prevention or treatment of acne.Type: ApplicationFiled: July 11, 2012Publication date: July 17, 2014Applicant: UNIVERSITAT ZURICHInventors: Dragana Jankovic, Magdalena Kistowiska, Emmanuel Contassot, Lars E. French, Samuel Gehrke
-
Patent number: 8778891Abstract: Peptides activating dermatopontin in the skin and cosmetic compositions including such peptide, in a physiologically suitable medium, are described. Methods of treating the cutaneous signs of aging and photoaging, and in particular wrinkles, sagging, and loss of volume and elasticity of the skin are also described.Type: GrantFiled: November 7, 2011Date of Patent: July 15, 2014Assignee: ISP Investments Inc.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Patent number: 8765198Abstract: The invention relates to a method for the cosmetic prevention and/or treatment of stretch marks on the skin, characterised in that the method comprises administering a composition containing arabinogalactan as an active principle to a person that may develop or has stretch marks. Said cosmetic composition can be administered in a topical or oral manner.Type: GrantFiled: November 9, 2009Date of Patent: July 1, 2014Assignee: Laboratoires ExpanscienceInventors: Philippe Msika, Caroline Baudouin, Dalale Naaimi, Franck Menu
-
Patent number: 8765689Abstract: Peptide compounds of the general formula (I) R1-(AA)n-X1—X2-Arg-Glu-Met-Asn-Trp-X3-(AA)p-R2 modulating the survivin protein are described. Furthermore, cosmetic or pharmaceutical compositions, including at least one peptide of the general formula (I), in a physiologically acceptable medium are described. Additionally, methods for treating the cutaneous signs of ageing and photo-ageing, treating the skin against external aggressions, and limiting hair loss and/or stimulating hair growth are described.Type: GrantFiled: January 13, 2011Date of Patent: July 1, 2014Assignee: ISP Investments Inc.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20140179616Abstract: Peptides of 5 to 14 amino acids in length that stimulate subcutaneous adipogenesis and uses thereof are provided.Type: ApplicationFiled: November 25, 2013Publication date: June 26, 2014Applicant: The Regents of The University of CaliforniaInventors: EVA A. TURLEY, SEYED BAHRAM BAHRAMI, MINA J. BISSELL
-
Publication number: 20140170165Abstract: A method of generating a hyper iNOS expressing cell includes administering to a myeloid derived cell an amount of a PPAR? agonist and an IL-6/STAT3 signaling pathway antagonist effective to substantially inhibit STAT3 activation in the cell and administering an inflammatory insult to the cell to stimulate hyper iNOS expression from the cell.Type: ApplicationFiled: February 28, 2013Publication date: June 19, 2014Applicant: CASE WESTERN RESERVE UNIVERSITYInventors: Kurt Q. Lu, Kevin D. Cooper
-
Publication number: 20140148394Abstract: The various embodiments relate to peptide antagonists of ?c-family cytokines, Interleukin-2 (IL-2), Interleukin-4 (IL-4), Interleukin-7 (IL-7), Interleukin-9 (IL-9), Interleukin-15 (IL-15), and Interleukin-21 (IL-21). The ?c-cytokines are associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (GvHD). Thus, inhibitors of ?c-cytokine activity are valuable therapeutic and cosmetic agents as well as research tools. Traditional approaches to inhibiting ?c-cytokine activity involve raising neutralizing antibodies against each individual ?c-cytokine family member/receptor subunit. However, success has been limited and often multiple ?c-cytokine family members co-operate to cause the disease state. Combinatorial use of neutralizing antibodies raised against each factor is impractical and poses an increased risk of adverse immune reactions.Type: ApplicationFiled: January 17, 2012Publication date: May 29, 2014Applicant: BIONIZ, LLCInventors: Yutaka Tagaya, Nazli Azimi
-
Publication number: 20140134222Abstract: The present invention provides a composition comprising an effective amount of benfotiamine and an effective amount of pyridoxamine in a suitable vehicle for topical application. The present compositions are useful in improving the appearance of aged skin characterized by wrinkles, loss of elasticity, and hyperpigmentation caused by chronoaging and/or photoaging of skin, by inhibiting particularly skin damage resulting from reactive carbonyl species (RCS), glycation of skin proteins, formation of advanced glycation endproducts (AGEs) and formation of advanced lipoxidation endproducts (ALEs).Type: ApplicationFiled: January 17, 2014Publication date: May 15, 2014Applicant: Tracie Martyn International, Inc.Inventor: Marius Morariu
-
Publication number: 20140135269Abstract: The present invention relates to methods and compositions for or treating human skin to reduce the visible appearance of fine lines and wrinkles as well as to enhance the skin's luminosity comprising applying an effective amount of a cosmetic composition of the invention to the skin for a period of time.Type: ApplicationFiled: September 26, 2013Publication date: May 15, 2014Inventor: Peter Thomas Roth
-
Patent number: 8722627Abstract: A peptidic hydrolyzate enriched in bioactive peptides is disclosed that is a proteasome activator. Cosmetic and pharmaceutical compositions are disclosed that include the peptidic hydrolyzate enriched in bioactive peptides in a physiologically acceptable medium. Also disclosed are methods for depigmenting, lightening and/or whitening the skin and treating hyperpigmentation blemishes as well as cutaneous signs due to photo-aging by administering the cosmetic compositions or pharmaceutical compositions.Type: GrantFiled: April 22, 2010Date of Patent: May 13, 2014Assignee: ISP Investments Inc.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20140120043Abstract: Disclosed is a stable cosmetic composition having a syrupy texture while not being sticky, and translucent (or even transparent) appearance. Further disclosed is a method of preparation of such composition, as well as a method of its use.Type: ApplicationFiled: June 15, 2012Publication date: May 1, 2014Applicant: Chanel Parfums BeauteInventors: Sophie Foucault, Veronique Kowandy, Veronique Trouillet
-
Patent number: 8710011Abstract: Peptides of general formula (I): R1-Wp-Xn-AA1-AA2-AA3-AA4-Ym-R2 their stereoisomers, mixtures thereof, and/or their cosmetically or pharmaceutically acceptable salts, a method of preparation, cosmetic or pharmaceutical compositions containing them and their use for the treatment, prevention and/or care of conditions, disorders and/or diseases of the skin, mucous membranes and/or scalp.Type: GrantFiled: February 16, 2010Date of Patent: April 29, 2014Assignee: Lipotec, S.A.Inventors: Nuria Garcia Sanz, Wim Van Den Nest, Cristina Carreno Serraima, Antonio Ferrer Montiel, Juan Cebrian Puche, Nuria Alminana Domenech
-
Patent number: 8710010Abstract: Peptides with general formula (I): R1-AA1-AA2-AA3-AA4-R2 its stereoisomers, mixtures thereof, and its cosmetically or pharmaceutically acceptable saits, a method of preparation, cosmetic or pharmaceutical compositions containing them and their use for the treatment and/or care of conditions, disorders and/or pathologies of the skin, mucous membranes, scalp and/or hair.Type: GrantFiled: October 2, 2009Date of Patent: April 29, 2014Assignee: Lipotec, S.A.Inventors: Wim Van Den Nest, Nuria Almiñana Domenech, Juan Cebrián Puche, Cristina Carreño Serraïma
-
Publication number: 20140113868Abstract: The present invention relates to a peptide analogue or a pharmaceutically acceptable salt thereof with excellent moisturizing effect, and use thereof for moisturization. More specifically, the present invention relates to a novel peptide analogue or a pharmaceutically acceptable salt thereof, a method for preparation thereof, a moisturizing cosmetic composition comprising the same as an active ingredient, and a pharmaceutical composition for prevention and treatment of xeroderma.Type: ApplicationFiled: May 22, 2012Publication date: April 24, 2014Applicant: INCOSPHARM CORPORATIONInventors: Kee-Don Park, Chae-Jin Lim, Seok-Jeong Yoon, Seon-Deok Kwon
-
Patent number: 8697656Abstract: The present invention concerns a peptide of following formula I: R being a side chain having at least one heteroatom selected from sulfur, nitrogen and oxygen in a carbonyl form (C?O); R1 being either H or a lipophilic chain; R2 being either OH or a lipophilic chain. More particularly the present invention concerns a cosmetic composition comprising a peptide as recited above and a physiologically acceptable medium. Results on the activity of the compounds are obtained and on the general state of the skin and its appendages, in particular via the stimulation of extracellular matrix components.Type: GrantFiled: January 15, 2010Date of Patent: April 15, 2014Assignee: SEDERMAInventors: Arnaud Fournial, Philippe Mondon, Olivier Peschard
-
Patent number: 8697652Abstract: This invention relates to the cosmetic use of at least one compound of formula (I) wherein A1 is the radical corresponding to D- or L-Ser A2 is the radical corresponding to D- or L-Asp or Glu, A3 is the radical corresponding to D- or L-Lys, Arg or Orn, A4 is the radical corresponding to D- or L-pro, R1, R2 and R3 are as defined in the claims as anti-aging and restructuring agents.Type: GrantFiled: June 22, 2005Date of Patent: April 15, 2014Assignee: Centre National de la Recherche Scientifique (CNRS)Inventors: Joanna Bakala, Jean-Yves Lallemand, Jian-Miao Liu, Jérôme Bignon
-
Publication number: 20140100171Abstract: A method of improving the appearance of aging skin includes applying to skin tissue having dullness or lack of radiance, or eleven lines, marionette lines, or horizontal forehead lines, or sagging skin, a composition containing S-acyl glutathione derivative having unsaturated or saturated C16 acyl group.Type: ApplicationFiled: December 9, 2013Publication date: April 10, 2014Inventor: Nicholas V. Perricone
-
Publication number: 20140100170Abstract: The present invention describes novel plant derived elastin-like peptides and peptidomimetics that may serve as functional ligands for elastin receptors and stimulate elastogenesis. The novel plant derived peptides provide an alternative (non-animal derived) source of GXXPG (SEQ ID NO. 2) containing peptides. The present invention also describes therapeutic compositions containing novel plant derived peptides or peptidomimetics useful in stimulating elastogenensis and capillary dilatation. The therapeutic compositions of the present invention that comprise novel plant derived peptides or peptidomimetics may be combined with other therapeutic agents.Type: ApplicationFiled: August 26, 2013Publication date: April 10, 2014Applicants: THE HOSPITAL FOR SICK CHILDREN, HUMAN MATRIX SCIENCES, LLCInventors: Felipe JIMENEZ, Thomas MITTS, Aleksander HINEK
-
Patent number: 8691247Abstract: The subject invention relates to a skin cream that can be used to moisturize and rejuvenate skin that has been damaged by exposure to sunlight or which has simply been affected over the years by intrinsic aging. It inhibits the formation of wrinkles and in some cases reduces the depth of existing wrinkles or eliminates them entirely. This invention is based upon the discovery that alkyl lactates, such as ethyl lactate, can be used to improve the penetration of active ingredients in skin care formulations deep into lower layers of the skin tissue. The present invention more specifically discloses a topical formulation comprising ascorbic acid, an amino acid selected from the group consisting of phenylalanine and tyrosine, a non-toxic zinc salt, an alkyl lactate, and a pharmaceutically acceptable carrier.Type: GrantFiled: December 17, 2007Date of Patent: April 8, 2014Assignee: Ad Lunam Labs Inc.Inventors: William H. Beeson, Alvin T. Rockhill
-
Patent number: 8685927Abstract: A cosmetic or pharmaceutical composition that includes a peptide hydrolyzate which is enriched in soothing bioactive peptide in a physiologically acceptable medium is described. Methods for applying such compositions to the skin are also described, in particular where the active principle activates 3-hydroxy-3-methylglutaryl-Coenzyme A (HMG-CoA) reductase in skin cells to treat skin irritations.Type: GrantFiled: April 15, 2010Date of Patent: April 1, 2014Assignee: ISP Investments Inc.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20140086981Abstract: Peptides of general formula (I): R1—Wn—Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp—Zq—R2 their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases which improve or are prevented by PGC-1? modulation.Type: ApplicationFiled: March 23, 2012Publication date: March 27, 2014Inventors: José María García Antón, Nuria Almiñana Domenech, Antonio Vicente Ferrer Montiel
-
Publication number: 20140086855Abstract: The present invention provides combined use of a carnosinase inhibitor with L-carnosine and its related substance, and a composition containing the same, which are useful for treatment or prevention of various diseases, improvement of health conditions, improvement of exercise ability, improvement of skin health, prevention of the side effects of alcohol drinking and the like in mammals including human.Type: ApplicationFiled: December 2, 2013Publication date: March 27, 2014Applicant: INNOVATIVE VISION PRODUCTS, INC.Inventors: Mark BABIZHAYEV, Kanji MEGURO
-
Publication number: 20140080761Abstract: The present invention was made in view of an object to produce a novel proteoglycan-containing material, and find a novel use and/or a superior effect of the proteoglycan-containing material. The present invention provides a proteoglycan-containing material obtained from fish cartilage, wherein the proteoglycan-containing material comprises an acidic saccharide component having a molecular weight of not less than 2000 kDa. The proteoglycan-containing material provides advantageous effects for skin-moisturizing and skin anti-aging, including a superior skin fibroblast proliferation effect, an effect of enhancing and improving the skin barrier function, an effect of enhancing and improving the skin's capability to produce collagen, a dermis-thickening inhibition effect, and the like.Type: ApplicationFiled: October 4, 2013Publication date: March 20, 2014Applicants: HIROSAKI UNIVERSITY, SUNSTAR INC.Inventors: Masashi GOTO, Kazushi YAMAMOTO, Youji KATOU, Yohtaro KATAGATA, Seiko ITOU
-
Patent number: 8673859Abstract: It has been discovered that granulocyte macrophage colony stimulating factor (“GM-CSF”) promotes migration of activated (but not differentiating) keratinocytes to wound sites. It was also discovered that GM-CSF increases the quantity and improves the quality of collagen. This growth factor specifically increases migration of keratinocytes of the “wound” phenotype but does not have significant effects upon differentiated keratinocytes. Examples demonstrate reversal of skin impairment in multiple animal models of diabetic skin imparment when provided in an effective amount over an effective time period. The examples also demonstrate the efficacy of the formulations in cosmetic applications.Type: GrantFiled: March 20, 2008Date of Patent: March 18, 2014Assignee: New York UniversityInventors: Harold Brem, Marjana Tomic
-
Patent number: 8674072Abstract: A peptidic hydrolyzate enriched in bioactive peptide, capable of reinforcing the skin barrier function and stimulating epidermal differentiation is described. Additionally, a cosmetic and/or pharmaceutical composition that includes a physiologically acceptable medium and the peptidic hydrolyzate as active principle are described. The cosmetic composition activates the HMG-CoA reductase in the cutaneous cells and treats the cutaneous signs of aging and photo-aging.Type: GrantFiled: April 15, 2010Date of Patent: March 18, 2014Assignee: ISP Investments Inc.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20140066381Abstract: Peptide compounds of the following general formula (I): R1-(AA)n-X1-X2-X3-Lys-Lys-Gln-Lys-Trp-X4-(AA)p-R2 are disclosed herein. The peptide compounds can be used as Telomeric repeat-binding factor 2 (TRF2) protein-modulating compounds and have a preventive action on deoxyribonucleic acid (DNA) double-strand breaks. In addition, cosmetic compositions that include at least one peptide of general formula (I) in a physiologically acceptable medium are disclosed along with methods for preventing and/or treating cutaneous signs of aging and photoaging.Type: ApplicationFiled: April 27, 2012Publication date: March 6, 2014Applicant: ISP INVESTMENTS INC.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20140066380Abstract: Short biologically active tetrapeptides are disclosed that are comprised of the sequences GxxG and PxxP where G (glycine) and P (proline) are maintained and x is a variable amino acid. The peptides can be used singly or in combination to stimulate production of extracellular matrix proteins in skin. A rapid, low-cost method of producing heterogenous formulations of tetrapeptides is disclosed.Type: ApplicationFiled: August 7, 2013Publication date: March 6, 2014Applicant: HELIX BIOMEDIX, INC.Inventors: Scott M. HARRIS, Timothy J. FALLA, Lijuan ZHANG
-
Publication number: 20140057850Abstract: The present invention relates to a peptide of the following formula (I) X1(X2)-X3-X4 or a salt or solvate thereof, wherein is an amino acid comprising two or more NH-functionalities, and X2, X3, and X4 are, independently from one another, an amino acid residue, and wherein the salt or solvate is preferably a physiologically acceptable salt or solvate.Type: ApplicationFiled: February 3, 2012Publication date: February 27, 2014Applicant: ORGANOBALANCE GMBHInventor: Christine Lang
-
Publication number: 20140057001Abstract: Provided herein are methods of using gaseous nitric oxide and/or at least one nitric oxide source to or decrease sebum production in the skin of a subject.Type: ApplicationFiled: October 31, 2013Publication date: February 27, 2014Applicant: Novan, Inc.Inventors: Susanne Bauman, Nathan Stasko
-
Publication number: 20140051640Abstract: The present patent application relates to a plant protein and mineral powder-based collagen mask, comprising the following constituents by weight percentage: Soya Protein: 1.2-1.5; Ethylene Glycol Phenyl Ether: 0.2-0.5; the rest is purified water. The plant protein and mineral powder-based collagen mask produced by the formula of the present patent application has a strong hydrating function. The moisture content of the plant protein and mineral powder-based collagen mask can be as high as 90%. When meet 37-38 degree body temperature, the plant protein and mineral powder-based collagen mask will release moisture slowly and fully releases after 4-5 hours, so that the skin always keep being moist. Meanwhile, the plant protein and mineral powder-based collagen mask of the present patent application will not suck back the moisture of the skin.Type: ApplicationFiled: July 30, 2013Publication date: February 20, 2014Inventor: Li YANG
-
Patent number: 8653031Abstract: We describe preparation of compounds of an AT1 receptor antagonist(s) and Angiotensin (1-7), for example, Angiotensin-(1-7) losartanate and analogues thereof, and/or mixtures of these systems, pharmaceutical compositions thereof and use of their derivative products. Cyclodextrins and derivatives thereof may be used for the micro-encapsulation of compounds, for example, Angiotensin (1-7) losartanate, liposomes and biodegradable polymers and/or mixtures of these systems and/or derivative products for the obtainment of nano- or microparticles as controlled or sustained release devices of Ang-(1-7) losartanate and analogues and/or mixtures thereof. The compounds may be used as agents for treating or preventing hypertension, cardiovascular diseases, heart hypertrophy, heart failure, coronary diseases, such as angina pectoris, endothelial disorder or endothelial lesions, as a consequence, for example, of atherosclerosis processes or in association with diabetes mellitus.Type: GrantFiled: October 30, 2006Date of Patent: February 18, 2014Assignee: Universidade Federal de Minas GeraisInventors: Rubén Dario Sinisterra Millán, Cynthia Fernades Ferreira Santos, Robson Augusto Souza Dos Santos, Ivana Silva Lula, Frederico Barros De Sousa, Pedro Pires Goulart Guimaraes, Angelo Márcio Leite Denadai
-
Publication number: 20140044799Abstract: The present invention concerns a molecular signature of cutaneous pigmentary spots, comprising the genes MXRA5, LYZ, CTSL2, PLAU, TIMP1, EFEMP1, ECM1, ASPN, HS3ST6, PAPLN, CHSY1 and FLRT2, and various applications of this signature. In particular, the invention concerns a method for characterizing a known or suspected pigmentary spot in a human being, comprising comparing the levels of expression in skin samples obtained from said spot and from adjacent undamaged skin, of at least one dermal gene linked to matrix remodelling or to its extracellular proteoglycan and glycoprotein components, selected from the list constituted by the genes MXRA5, LYZ, CTSL2, PLAU, TIMP1, EFEMP1, ECM1, ASPN, HS3ST6, PAPLN, CHSY1 and FLRT2. The invention also concerns methods for evaluating the efficacy of a pigmentary spot treatment, cosmetic and therapeutic methods for the treatment of pigmentary spots, and various modulators for said genes, and their use.Type: ApplicationFiled: April 20, 2012Publication date: February 13, 2014Applicant: L'OREALInventors: Francoise Bernerd, Christine Duval, Olivier De Lacharriere, Stephanie Nouveau, Xavier Marat
-
Publication number: 20140045767Abstract: A topical composition for application to aging skin, including an effective amount of S-acyl glutathione derivative of formula (I) wherein R1 consists of an unsaturated or saturated C16 acyl group and R2 is a hydrogen, aliphatic or aromatic acyl group; and a dermatologically acceptable carrier. Preferred compositions include about 1.0% to about 3.0% by weight of S-palmitoyl glutathione.Type: ApplicationFiled: October 23, 2013Publication date: February 13, 2014Inventor: Nicholas V. Perricone
-
Publication number: 20140044655Abstract: This invention relates to new peptides activating extracellular matrix protein synthesis in the skin. This invention also relates to a cosmetic composition comprising such peptides as an active agent and the use of such a composition for increasing the extracellular matrix protein expression, delaying the appearance of or reducing wrinkles, sagging and loss of skin volume, and dehydration of the skin. The invention finally relates to cosmetic care methods intended to delay or treat cutaneous signs of aging and photoaging.Type: ApplicationFiled: February 17, 2012Publication date: February 13, 2014Applicant: ISP INVESTMENTS INC.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20140045766Abstract: Methods of restoring the circadian rhythm and resynchronizing the biological clock of cells are described. The methods include topically applying a topical composition comprising a cosmetically acceptable medium and an effective quantity of a peptide compound of general formula (I), R1-(AA)n-X1-Ser-Thr-Pro-X2-(AA)p-R2, to skin or skin appendages to be treated.Type: ApplicationFiled: July 5, 2013Publication date: February 13, 2014Applicant: ISP INVESTMENTSInventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Publication number: 20140037768Abstract: A method for keratin hyperproliferation disorders such as corns, calluses, or keratosis pilaris (KP) by administering to a subject experiencing the disorder a therapeutically effective amount of an RNA sequence which inhibits expression of a gene encoding for a keratin selected from the group consisting of K6a, K6b, K16, K17, and combinations thereof.Type: ApplicationFiled: July 1, 2013Publication date: February 6, 2014Inventors: Roger Louis Kaspar, Robyn Patricia Hickerson
-
Publication number: 20140037560Abstract: This invention relates to peptide compounds of general formula (I) R1-(AA)n-X1—X2—X3-Asp-Leu-Lys-Lys-X4—X5-(AA)p-R2. Said peptide compounds have an action on the SCF/c-Kit signaling pathway and thus make it possible to protect skin pigment structures from external stresses. In addition, this invention relates to a cosmetic or pharmaceutical composition comprising at least one peptide of general formula (I), in a physiologically acceptable medium, and its use for attenuating age-related pigmentation defects and the effects of photoaging on the skin. The invention finally relates to various cosmetic treatment methods using said peptides according to the invention.Type: ApplicationFiled: January 30, 2012Publication date: February 6, 2014Applicant: ISP INVESTMENTS INC.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto